Home » Newsletters » BioWorld Asia

BioWorld Asia

July 15, 1998

View Archived Issues

Former Biotech Execs Seek Compensation From Firms

Cyclacel Licenses Rights To Drug Delivery Agent

Irish EPA, Monsanto In Dock Over Genetically Altered Beets

German Start-Up Mologen To Develop DNA Vaccines

New Test Speeds Diagnosis Of Fetal Chromosome Problems

Trinity Biotech Takes Over Diatech's Microzyme Products

ExonHit Gets FFr5M To Support Gene Expression Technology

StressGen Sets Up Network For Cell Protection Studies

Stanford Rook Progressing To Phase III With Cancer Therapy

Other News To Note

EU Mulls Consistency Rules For Biotechnology Drugs

Shield Reports '98 Profit Says '99 Won't Be As Good

Surgen Seeks Partners For Heart Disease Studies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Maintenance, man: Lilly’s phase III weight trial hits goals
BioWorld
Eli Lilly and Co. took another step toward adding a way for patients to hang onto their weight loss when the firm disclosed positive top-line data from the phase...
AI drug developer Insilico to raise $292 million in Hong Kong IPO
BioWorld
Insilico Medicine Inc. plans to raise HK$2.27 billion (US$292 million) in its IPO on the Hong Kong Securities Exchange to advance its clinical pipeline and invest...